This podcast segment features the Q&A from IQVIA’s May 25, 2022 webinar hosted IQVIA experts Raina Olexa, Senior Principal Scientist Regulatory Science and Strategy, and Mui Van Zandt, VP and GM Real World Data and Technology, as they answer questions on embracing FDA’s guidance on the use of real world data (RWD) to understand how your organization can navigate data quality, curation, and management challenges for better research.
If you do not see the embedded media player above, access the podcast episode here.
The entire healthcare ecosystem is embracing a mission of innovation, including regulatory agencies like the FDA. Guidance documents on the use of RWD released over the past year are shaping the future of evidence generation and Regulatory Science. In addition to new methods and approaches, quality and curation of RWD collected from a variety of sources are key themes in FDA’s guidance and can impact utilization. In this webinar, Mui Van Zandt, BS and Raina Olexa, MS discuss how your organization can navigate data quality, curation, and management challenges for better research.